7-hydroxy-2-n,n-dipropylaminotetralin has been researched along with Migraine Disorders in 1 studies
7-hydroxy-2-N,N-dipropylaminotetralin: RN given refers to cpd without isomeric designation
Migraine Disorders: A class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. The two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms). (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barbanti, P | 1 |
| Fabbrini, G | 1 |
| Ricci, A | 1 |
| Pascali, MP | 1 |
| Bronzetti, E | 1 |
| Amenta, F | 1 |
| Lenzi, GL | 1 |
| Cerbo, R | 1 |
1 other study available for 7-hydroxy-2-n,n-dipropylaminotetralin and Migraine Disorders
| Article | Year |
|---|---|
Migraine patients show an increased density of dopamine D3 and D4 receptors on lymphocytes.
Topics: Adult; Female; Humans; Immunochemistry; Lymphocytes; Male; Middle Aged; Migraine Disorders; Radiolig | 2000 |